EQS-News: Innovative MedTech Announces Name Change to "AnTix Holdings", and Shifts Its Business Model

Significant Corporate Changes Lay Foundation for Next Phase

BLUE ISLAND, IL - October 17, 2025 (NEWMEDIAWIRE) - Innovative MedTech, Inc. (the “Company”) (OTC: IMTH) announced today that it has completed its planned corporate rebranding and name change to AnTix Holdings, Inc., to better align with the new strategic direction of the Company.

“This marks an exciting milestone for our Company,” said Michael J. Friedman, President and CEO of AnTix Holdings, Inc. “Through this rebranding, we are expanding into the growing online ticketing and entertainment technology sector, where we see meaningful opportunities to apply artificial intelligence and Web 3.0 tools to improve the ticketing and live experience for consumers and partners alike. Our ticketing technology has begun to generate revenues for the Company and we believe that this will provide a strong foundation for our next phase of growth.”

He added, “Our goal is to build value through innovation, execution and acquisition in a market that is ripe for significant technological change. We are enthusiastic about this transition and remain focused on strengthening the Company’s position and appeal to a broad base of investors, while increasing shareholder value. We look forward to sharing more information on our plans in the very near future.”

Name Change

On September 19, 2025, we filed with the State of Delaware a Certificate of Amendment to our Amended and Restated Certificate of Incorporation to change our corporate name from “Innovative MedTech, Inc.” to “AnTix Holdings, Inc.” 

Our common stock will continue to trade under the ticker symbol “IMTH.” We intend to file with FINRA to effectuate the name change and change our ticker symbol from “IMTH” to a new ticker symbol. Outstanding stock certificates for shares of the Company are not affected by the name change; they continue to be valid and need not be exchanged at this time.

About AnTix Holdings, Inc.

About AnTix Holdings, Inc. AnTix Holdings, Inc. (OTC: IMTH or the “Company”) is a technology company that delivers artificial intelligence to online ticketing, with a mission to bring transparency, efficiency and personalization to the ticketing and entertainment industry.  Additionally, IMTH is the exclusive licensor for the Oral Thrush application of Shear Kershman Labs’ BioViscid™ bio-adhesive encapsulation.  For more information, visit https://www.antixholdings.com

Safe Harbor Statement

Statements in this press release that are not historical are forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are only predictions and are not guarantees of future performance and are based on certain assumptions and reflect management's current expectations. These forward-looking statements are subject to a number of risks and uncertainties that could cause actual results or events to differ materially from current expectations and are subject to change at any time. Some of these factors include: general global economic conditions; general industry and market conditions, sector changes and growth rates; uncertainty as to whether our strategies and business plans will yield the expected benefits; increasing competition; availability and cost of capital; the ability to identify, develop and achieve commercial success; the level of expenditures necessary to develop, maintain and improve the quality of products or services; changes in the economy; changes in laws and regulations, including codes and standards, intellectual property rights, and tax matters; or other matters not anticipated; our ability to secure and maintain strategic relationships and distribution agreements. These and other important factors may cause the Company’s actual results, performance, or achievements to differ materially from any future results, performance, achievements or plans expressed or implied by these forward-looking statements. The Company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

IMTH Contact: Media Relations:
Michael Friedman
708-925-9424ir@antixholdings.com

View the original release on www.newmediawire.com

News Source: Innovative MedTech, Inc.